Update on ICOS: A Possible Target for Turning-Off Autoimmunity

E-ISSN： 2212-3334|3|3|205-213

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.3, 2009-11, pp. : 205-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Use of Vitamin D and its Analogues in Autoimmunity

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 22-34

Bentham Science Publishers

Access to resources Recommend Favorite

AEA Technology's NNDTC – An update

Insight - Non-Destructive Testing and Condition Monitoring, Vol. 45, Iss. 3, 2003-03 ,pp. : 218-219

The British Institute of Non-Destructive Testing

Access to resources Recommend Favorite

Molluscum Contagiosum: An Update

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 11, Iss. 1, 2017-08 ,pp. : 22-31

Bentham Science Publishers

Access to resources Recommend Favorite

Herpes Labialis: An Update

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 11, Iss. 2, 2017-12 ,pp. : 107-113

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 8, Iss. 2, 2014-05 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite